US Patent 7238663 Pre-mixes of GLP-1 and basal insulin

Patent 7238663 was granted and assigned to Eli Lilly on July, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7238663

Date of Patent

July 3, 2007

Patent Application Number

10486333

Date Filed

August 23, 2002

Patent Citations Received

‌

US Patent 12102663 Treatment of post-bariatric hypoglycemia with exendin (9-39)

‌

US Patent 11752198 GLP-1 compositions and uses thereof

Patent Primary Examiner

‌

Cecilia J. Tsang

Patent abstract

The present invention encompasses pre-mixed formulations comprising a GLP-1 polypeptide and a basal insulin.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7238663 Pre-mixes of GLP-1 and basal insulin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API